Ynvisible Interactive Inc. (TSXV: YNV) has released a multi-part update covering progress on its commercial collaboration with consumer diagnostics company Sapphiros, the appointment of a new Chief Financial Officer, and a voluntary shift to semi-annual financial reporting. Sapphiros is targeting a 2027 commercial launch following clinical trial completion expected in Q4 2026, with Ynvisible's e-paper displays integrated into the diagnostic platform. Investors may be watching closely given the potential for high-volume production that the company describes as a significant long-term opportunity.

Key Points

  • Ynvisible Interactive Inc. (TSXV: YNV | FSE: 1XNA | OTCQB: YNVYF)
  • Sapphiros clinical trials are progressing, with completion expected in Q4 2026 and a planned 2027 commercial launch
  • Commercialisation volumes could reach the high millions of units annually, per current projections disclosed by the company
  • Inês Paramés appointed CFO effective September 1, 2026; semi-annual reporting adopted beginning Q3 2026

Sapphiros Collaboration Targets High-Volume Healthcare Application

Ynvisible's ultra-low-power e-paper displays are integrated into Sapphiros's next-generation digital diagnostic platform, and both companies are actively preparing for high-volume production. The release states that commercialisation volumes could reach the high millions of units annually based on current projections, representing what the company characterises as a significant long-term opportunity. Sapphiros is simultaneously advancing regulatory approvals, product optimisation, and manufacturing scale-up alongside its clinical programme, all in preparation for the planned 2027 commercial launch. CEO Ramin Heydarpour stated the programme is "positioned to become one of Ynvisible's most significant high-volume healthcare applications."

Inês Paramés Appointed as Chief Financial Officer

The company announced the appointment of Inês Paramés as Chief Financial Officer, effective September 1, 2026. The disclosure notes she has been with Ynvisible for more than four years, progressively taking on broader responsibilities across the global finance function and directing the company's finances for the past two years. Her predecessor, Darren Urquhart, stepped down as CFO effective August 31, 2026, after serving in the role since 2018. CEO Heydarpour thanked Urquhart for his eight years of service and expressed confidence that Paramés brings the financial expertise and continuity needed to support Ynvisible's commercial-scale growth strategy.

Voluntary Shift to Semi-Annual Financial Reporting Aims to Reduce Costs

Ynvisible has voluntarily elected to adopt semi-annual financial reporting under a program introduced by the Canadian Securities Administrators. The first quarter for which the company will rely on this exemption is Q3 2026, ending September 30, 2026, meaning no interim financial statements or MD&A will be filed for that period. The company stated the change is intended to optimise corporate resources and lower administrative and compliance costs associated with quarterly reporting schedules, redirecting management focus and capital toward commercial execution. Ynvisible confirmed it will continue providing operational updates and press releases to shareholders alongside mandated semi-annual and annual financial statements.